share_log

Evogene Analyst Ratings

Benzinga ·  Aug 18, 2023 23:09
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
08/18/2023 391.72% Lake Street $2 → $3 Maintains Buy
07/21/2023 883.45% Roth MKM $1 → $6 Maintains Buy
05/02/2023 227.82% Lake Street → $2 Initiates Coverage On → Buy
09/12/2022 1211.26% Aegis Capital $10 → $8 Maintains Buy
09/02/2022 391.72% Roth MKM $6 → $3 Maintains Buy
10/08/2021 1047.35% Roth Capital → $7 Initiates Coverage On → Buy
07/29/2021 1539.08% Aegis Capital → $10 Initiates Coverage On → Buy
12/01/2020 1375.17% Cantor Fitzgerald → $9 Initiates Coverage On → Overweight

What is the target price for Evogene (EVGN)?

The latest price target for Evogene (NASDAQ: EVGN) was reported by Lake Street on August 18, 2023. The analyst firm set a price target for $3.00 expecting EVGN to rise to within 12 months (a possible 391.72% upside). 5 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Evogene (EVGN)?

The latest analyst rating for Evogene (NASDAQ: EVGN) was provided by Lake Street, and Evogene maintained their buy rating.

When is the next analyst rating going to be posted or updated for Evogene (EVGN)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Evogene, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Evogene was filed on August 18, 2023 so you should expect the next rating to be made available sometime around August 18, 2024.

Is the Analyst Rating Evogene (EVGN) correct?

While ratings are subjective and will change, the latest Evogene (EVGN) rating was a maintained with a price target of $2.00 to $3.00. The current price Evogene (EVGN) is trading at is $0.61, which is out of the analyst's predicted range.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment